SCHEMBL12659792

SCHEMBL12659792

CCCCCCC(CCCCCC)N1C(=O)c2ccc3c4ccc5c6c(ccc(c7ccc(c2c37)C1=O)c64)C(=O)N(CCCN1C(=O)c2ccc3c4ccc6c7c(ccc(c8ccc(c2c38)C1=O)c74)C(=O)N(C(CCCCCC)CCCCCC)C6=O)C5=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ STAT3 P40763 1/20 0.52
▸ HIF1A Q16665 1/20 0.52
▸ TERT O14746 7/20 0.48
▸ MEN1 O00255 2/20 0.42
▸ RGS12 O14924 2/20 0.42
▸ HTT P42858 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ PABPC1 P11940 1/20 0.42
▸ RECQL P46063 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ TLR9 Q9NR96 2/20 0.42
▸ USP2 O75604 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7485629 0.97 STAT3 (0.52) STAT3HIF1ATERTMEN1RGS12
SCHEMBL23987285 0.93 STAT3 (0.48) STAT3HIF1ATERTMEN1RGS12
SCHEMBL15810567 0.92 HIF1A (0.42) STAT3HIF1ATERTMEN1RGS12
SCHEMBL17190576 0.92 HIF1A (0.42) STAT3HIF1ATERTMEN1RGS12
SCHEMBL7487209 0.92 HIF1A (0.42) STAT3HIF1ATERTMEN1RGS12
SCHEMBL12869474 0.92 HIF1A (0.42) STAT3HIF1ATERTMEN1RGS12
SCHEMBL7485582 0.92 HIF1A (0.42) STAT3HIF1ATERTMEN1RGS12
SCHEMBL15764531 0.92 HIF1A (0.42) STAT3HIF1ATERTMEN1RGS12
SCHEMBL22015900 0.92 HIF1A (0.42) STAT3HIF1ATERTMEN1RGS12
SCHEMBL19237463 0.92 HIF1A (0.42) STAT3HIF1ATERTMEN1RGS12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7947837-B2 dimeric and polymeric compounds based upon fused ring tetracarboxylic imides, used as electronic thin films on substrates; transistors POLYERA CORPORATION (US) 2011-05-24 — — US disclosed
US-20080167435-A1 Organic semiconductor materials and methods of preparing and use thereof USINVEST LLC 2008-07-10 — — US disclosed
WO-2008051552-A2 ORGANIC SEMICONDUCTOR MATERIALS AND METHODS OF PREPARING AND USE THEREOF NORTHWESTERN UNIVERSITY (US) 2008-05-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080167435-A1 Organic semiconductor materials and methods of preparing and use thereof PNN, NBAS, PIEZO1 STAT3 4053/4885HIF1A 4329/4885TERT 1624/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback